The randomised thoracoscopic talc poudrage+indwelling pleural catheters versus thoracoscopic talc poudrage only in malignant pleural effusion trial (TACTIC): study protocol for a randomised controlled trial
Dipper A. et al, (2023), BMJ Open Respiratory Research, 10, e001682 - e001682
Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial
Psallidas I. et al, (2022), The Lancet Respiratory Medicine, 10, 139 - 148
Increasing adherence to CPAP in mild OSA using remote monitoring: the merge randomised controlled trial
Kelly JL. et al, (2022), JOURNAL OF SLEEP RESEARCH, 31
Continuous positive airway pressure versus standard care for the treatment of people with mild obstructive sleep apnoea (MERGE): a multicentre, randomised controlled trial
Wimms AJ. et al, (2020), The Lancet Respiratory Medicine, 8, 349 - 358
Findings of a feasibility study of pre-operative pulmonary rehabilitation to reduce post-operative pulmonary complications in people with chronic obstructive pulmonary disease scheduled for major abdominal surgery
Marlow LL. et al, (2020), F1000Research, 9, 172 - 172
The MERGE Randomized Controlled Trial: Effect of Continuous Positive Airway Pressure (CPAP) on Vitality in Mild Obstructive Sleep Apnea
Kelly JL. et al, (2020), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 201
Antibiotic Review Kit for Hospitals (ARK-Hospital): study protocol for a stepped-wedge cluster-randomised controlled trial
Walker AS. et al, (2019), Trials, 20
Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCT
Kapoor M. et al, (2019), Health Technology Assessment, 23, 1 - 140
Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion
Rahman NM. et al, (2015), JAMA, 314, 2641 - 2641
Intrapleural use of tissue plasminogen activator and DNase in pleural infection
Rahman NM. et al, (2011), New England Journal of Medicine, 365, 518 - 526
Intrapleural Use of Tissue Plasminogen Activator and DNase in Pleural Infection
Rahman NM. et al, (2011), New England Journal of Medicine, 365, 518 - 526
The Relationship Between Chest Tube Size and Clinical Outcome in Pleural Infection
Rahman NM. et al, (2010), Chest, 137, 536 - 543
The relationship between chest tube size and clinical outcome in pleural infection
Rahman NM. et al, (2010), Chest, 137, 536 - 543
PRIMARY RESULT OF THE SECOND MULTICENTRE INTRAPLEURAL SEPSIS (MIST2) TRIAL; RANDOMISED TRIAL OF INTRAPLEURAL TPA AND DNASE IN PLEURAL INFECTION
Rahman NM. et al, (2009), THORAX, 64, A1 - A1
Use of lipoteichoic acid-T for pleurodesis in malignant pleural effusion: a phase I toxicity and dose-escalation study
Rahman NM. et al, (2008), The Lancet Oncology, 9, 946 - 952
A PHASE I TOXICITY, DOSE FINDING AND PRELIMINARY EFFICACY ASSESSMENT OF LIPOTEICHOIC ACID-T FOR PLEURODESIS IN MALIGNANT PLEURAL EFFUSION
Rahman NM. et al, (2008), THORAX, 63, A48 - A49
The relation between chest tube bore, clinical outcome and tube-related adverse events in pleural infection
Rahman NM. et al, (2007), THORAX, 62, A49 - A49